Hyperglycemia AltersO-GlcNAcylation Patterns of Hepatocytes in Mice Treated With Hepatoxic Carcinogen

Abstract

Background/Aim: Diabetes mellitus (DM) is an established risk for hepatocellular carcinoma (HCC), with unclarified mechanisms. This study investigated the effects of hyperglycemia on O-GlcNacylation in hepatocytes and its associations with hepatocarcinogenesis. Materials and Methods: Mouse and human HCC cell lines were used in an in vitro model of hyperglycemia. Western blotting was used to determine the effects of high glucose on O-GlcNacylation in HCC cells. Twenty 4-week-old C3H/HeNJcl mice were randomized into four groups: non-DM control, non-DM plus diethylnitrosamine (DEN), DM, and DM plus DEN. DM was induced using intraperitoneal injection of a single high dose of streptozotocin. DEN was used to induce HCC. All mice were euthanized at week 16 after DM induction, and the liver tissues were histologically examined using hematoxylin and eosin, and immunohistochemistry. Results: High glucose increased O-GlcNacylated proteins in mouse and human HCC cell lines compared with those cultured at normal glucose concentration. Mice with hyperglycemia or DEN treatment had increased O-GlcNacylated proteins in hepatocytes. No gross tumors were evident at the end of the experiment but hepatic morbidity was observed. Mice with hyperglycemia and DEN treatment showed greater histological morbidity in their livers, i.e. increased nuclear size, hepatocellular swelling and sinusoidal dilatation, compared with mice in the DM group or treated with DEN alone. Conclusion: Hyperglycemia increased O-GlcNAcylation in both in vitro and animal models. Increased O-GlcNAcylated proteins may be associated with hepatic histological morbidities which then promote HCC development in carcinogen-induced tumorigenesis.

Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity

“…One of the mechanisms of glucose toxicity in hyperglycemia is increased O-GlcNAcylation. Increased O-GlcNAcylated proteins may be associated with hepatic histological morbidities [ 48 ]. In the liver, transcriptional factors, FoxO1, PGC-1α, CRTC2, LXR and ChREBP, are found to be regulated by O-GlcNAcylation, leading to enhanced expression of gluconeogenic and lipogenic genes.…”

Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo

“…Formalin-fixed paraffin-embedded tumor tissues were cut into 6-µm-thick slices and mounted onto glass slides. The tissues were stained with hematoxylin (Polyscience Inc., Warrington, PA, USA) for 40 s and with eosin (Sigma-Aldrich) for 30 s. The tissue sections were examined under a light microscope (Nikon, Tokyo, Japan) after mounting with Permount mounting medium (Fisher Scientific, Miami, FL, USA) 41 .…”